Highlights and Quick Summary
- Operating CF per Share for the quarter ending March 31, 2023 was -0.14 (a -32.08% decrease compared to previous quarter)
- Year-over-year quarterly Operating CF per Share decreased by -75.76%
- Annual Operating CF per Share for 2022 was -1.95 (a 246.67% increase from previous year)
- Annual Operating CF per Share for 2022 was -0.56 (a -81.22% decrease from previous year)
- Annual Operating CF per Share for 2021 was -2.99 (a 247.65% increase from previous year)
- Twelve month Operating CF per Share ending March 31, 2023 was -0.67 (a 1.79% increase compared to previous quarter)
- Twelve month trailing Operating CF per Share decreased by -65.52% year-over-year
Trailing Operating CF per Share for the last four month:
| 31 Mar '23 | 31 Dec '22 | 30 Sep '22 | 30 Jun '22 |
|---|---|---|---|
| -0.67 | -0.66 | -288.51 | -1.95 |
Visit stockrow.com/BNTC
for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow
statement with 10 years of data, and state-of-the-art screener.
Historical Operating CF per Share of Benitec Biopharma Limited
Most recent Operating CF per Shareof BNTC including historical data for past 10 years.Interactive Chart of Operating CF per Share of Benitec Biopharma Limited
Benitec Biopharma Limited Operating CF per Share for the past 10 Years (both Annual and Quarterly)
| Year | Q1 | Q2 | Q3 | Q4 | Fiscal Year |
|---|---|---|---|---|---|
| 2023 | -0.14 | – | – | – | – |
| 2022 | -0.21 | -74.49 | -0.59 | -0.42 | -1.95 |
| 2021 | -0.41 | -104.6 | -1.2 | -0.42 | -2.99 |
| 2020 | -0.77 | -2.13 | -616.67 | -156.7 | -1477.45 |
| 2019 | – | – | 0.0 | -0.63 | 5.59 |
| 2018 | – | – | – | – | -10.82 |
| 2017 | – | – | – | -3.51 | -10.71 |
| 2016 | – | -7.12 | 0.0 | 0.0 | -31.03 |
| 2015 | – | – | 0.0 | 0.0 | -21.08 |
| 2014 | – | – | 0.0 | 0.0 | -28.25 |
| 2013 | 0.0 | – | – | – | -0.81 |
Business Profile of Benitec Biopharma Limited
Sector: Healthcare
Industry: Biotechnology